End-of-day quote
Other stock markets
|
||
- | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 17-04-30 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 17-09-24 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 21-12-31 |
Corporate Officer/Principal | - | 16-12-31 | |
Corporate Officer/Principal | - | 20-11-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 19-12-16 |
Bruce Resnick
BRD | Director/Board Member | - | 19-12-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,944,971 | 36,835,813 ( 94.58 %) | 421,677 ( 1.083 %) | 94.58 % |
Company contact information
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.comSector
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.44% | 21.31B | |
-16.61% | 21.21B | |
-5.24% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- Stock
- Stock
- Company Spark Therapeutics Inc